With this antigen test, the bacterium Chlamydia trachomatis can be detected directly. This means that this test is also suitable for further check-ups following successful treatments. 
Infections with Chlamydia trachomatis are the most common sexually transmitted diseases. This mostly asymptomatic disease is the greatest cause of infection-induced infertility. 

An infection can lead to various symptoms and long-term consequences:

  • for women: cervicitis, urethritis, peritoneal symptoms or sterility
  • for men: urethritis, prostatitis or epididymitis
  • for new-born babies: pneumonia or inclusion conjunctivitis

Early detection of the Chlamydia trachomatis infection can prevent from later complications such as infertility or the development of other illnesses. This method of diagnosis enables higher quality treatment.

The chlamyCARE-C test system includes all instruments for use: sterile swabs (one for preparation and one for sample collection), test cassette and buffer bottles A & B. It is not necessary to incubate the sample at 80°C.

chlamyCARE-C detects the presence of antigens already with a 1.6 x 104 elementary corpuscles/ml and records - according to clinical user trials - 85.7% sensitivity and 98.3% specificity rates (results in comparison with PCR (Polymerase Chain Reaction)). 

20 test cassettes, extraction buffer A & B, 20 sample containers, user instruction - depending on the requirements with 40 sterile cervical-swabs or without swabs.
Quick immunochromatographic test
Chlamydia trachomatis antigen, serotypes antigen, LGVI-LGV111
Sample type: 
Endocervical smear
Order number: 

490207-20: 20 test sets including 40 cervical-swabs
0702022: 20 test sets without swabs